Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07535606 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate ALN-4915 in Adult Healthy Volunteers

Name: A Study to Evaluate ALN-4915 in Adult Healthy Volunteers — clinical trial record (NCT07535606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorAlnylam Pharmaceuticals

Started2026-03-02

View on ClinicalTrials.gov ↗

Amendment history

2026-08-11

4 amendments v1-v4

4 re-verifications since 2026-05-12, no change to tracked fields

2026-04-10

Original filing

Alnylam Pharmaceuticals

31 trials monitored

See 5 trials at risk

The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of ALN-4915.

Trial Details

NCT Number	NCT07535606
Lead Sponsor	Alnylam Pharmaceuticals
Conditions	Healthy Volunteers
Enrollment	44 participants
Start Date	2026-03-02
Primary Completion	2027-07-31 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-16